IBEX’s shares rose 7.5% after the company reported 12% fourth-quarter revenue growth to $164.3 million and 15% full-year organic growth, alongside accelerating AI-agent traction and record profitability and cash-flow metrics.
The stock rose 15.6% as ibex reported sustained double-digit revenue growth driven by strong client retention, accelerating growth in the health tech vertical, and the promising strategic partnership integrating AI technology, signaling optimism about its differentiated positioning in a shifting BPO landscape.